Answer
Atogepant selectively blocks CGRP from binding to its receptor and antagonizes CGRP receptor function.
Sources for this answer
- AQUIPTA 10 mg tabletsAbbVie Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked